CNSP vs LNC · $6.6M cap vs P/E 4.9, rev $9.85B
CNS Pharmaceuticals Inc (CNSP) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
CNSP does not have a complete income-statement cache yet.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
CNSP currently screens at market cap $6.6M. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the CNSP and LNC stock pages for the full models.
Not investment advice.